中国肺血栓栓塞登记研究:急性肺栓塞风险分层、院内管理与死亡率趋势
基于中国多中心CURES登记研究,纳入2009至2015年7438例急性症状性肺栓塞成人患者,回顾性分析风险分层、治疗及院内死亡趋势。高危、中危、低危比例分别为4.2%、67.1%、28.7%,全因死亡率从3.1%降至1.3%,初始系统性溶栓从14.8%降至5.0%。
要点
- 高危、中危、低危肺栓塞比例分别为4.2%、67.1%、28.7%
- 全因死亡率从2009年3.1%降至2015年1.3%
- 初始系统性溶栓使用率从14.8%降至5.0%
核心结论
- 急性肺栓塞全因死亡率显著下降,同时初始治疗模式发生改变。
- 研究结果强调全国范围内风险分层指导管理的重要性。
研究设计与样本
- 中国多中心回顾性登记研究(CURES),纳入2009至2015年7438例急性症状性肺栓塞成人患者。
- 风险分层依据血流动力学状态和简化肺栓塞严重指数(sPESI)按2014年ESC/ERS指南回顾性分类。
主要发现
- 高危(血流动力学不稳定)、中危(sPESI≥1)、低危(sPESI=0)比例分别为4.2%、67.1%、28.7%。
- CT肺动脉造影是最广泛使用的诊断方法(87.6%),抗凝是最常采用的初始治疗(83.7%)。
- 2009至2015年全因死亡率从3.1%降至1.3%(校正趋势P=0.0003)。
- 初始系统性溶栓使用率从14.8%降至5.0%(趋势P<0.0001)。
- 血流动力学稳定和不稳定患者共有的全因死亡预测因素包括合并癌症、高龄和肾功能受损。
临床怎么用
- 临床应依据血流动力学状态和sPESI评分进行风险分层以指导急性肺栓塞管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Similar trends of management and in-hospital mortality of acute pulmonary embolism (PE) have been reported in European and American populations. However, these tendencies are not clear in Asian countries. We retrospectively analysed the trends of risk stratification, management and in-hospital mortality for patients with acute PE through a multicentre registry in China (CURES).Adult patients with acute symptomatic PE were included between 2009 and 2015. Trends in disease diagnosis, treatment and death in hospital were fully analysed. Risk stratification was retrospectively classified by haemodynamic status and the simplified Pulmonary Embolism Severity Index (sPESI) score according to the 2014 European Society of Cardiology/European Respiratory Society guidelines.Among 7438 patients, the proportions with high (haemodynamic instability), intermediate (sPESI≥1) and low (sPESI=0) risk were 4.2%, 67.1% and 28.7%, respectively. Computed tomographic pulmonary angiography was the most widely used diagnostic approach (87.6%) and anticoagulation was the most frequently adopted initial therapy (83.7%). Between 2009 and 2015, a significant decline was observed for all-cause mortality (from 3.1% to 1.3%, adjusted pfor trend=0.0003), with a concomitant reduction in the use of initial systemic thrombolysis (from 14.8% to 5.0%, pfor trend<0.0001). The common predictors for all-cause mortality shared by haemodynamically stable and unstable patients were co-existing cancer, older age and impaired renal function.The considerable reduction of mortality over the years was accompanied by changes in initial treatment. These findings highlight the importance of risk stratification-guided management throughout the nation.
引用
- Zhai Z, Wang D, Lei J, et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES). Eur Respir J. 2021. PMID: 33986031. doi:10.1183/13993003.02963-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。